Archives

by in
Entry Author Date Location
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
Bristol-Myers Cuts Clinical Team at ZymoGenetics Seattle Site 11/07/13 Seattle
What Can Washington Do to Revitalize Biotech? Q&A With Gov. Inslee 10/25/13 Seattle
Medicines Buys ProFibrix, Led by Former Zymonite, for $90M 08/05/13 Seattle
NanoString Technologies Maneuvers In Line for $86M IPO 05/20/13 Seattle
Blaze Bioscience Caps Off $8.5M Financing, Charges Toward Clinic 02/22/13 Seattle
The Intersection of the Double Helix and Life Sciences in Seattle 01/22/13 Seattle
How To Build a Biotech Cluster That Isn’t Boston or SF 11/20/12 National
Novo Nordisk Weaves Itself Into Seattle Biotech, With Diabetes R&D 07/06/12 Seattle
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors 10/18/11 Seattle
How Seattle Set Out to Create a Biotech Hub and Fostered a Global Health Nexus 08/08/11 Seattle
The Missing Ingredient in Today’s Biotech: Guts 07/11/11 National
Editor’s Picks: Xconomy Seattle’s Top Stories of the First Quarter 03/31/11 Seattle
Dendreon Makes It Official, Grabs Downtown Office and Former Zymo Lab Building 03/01/11 Seattle
Washington’s Innovation Corridor a Key to Recovery 02/18/11 Seattle
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News 01/27/11 Seattle
Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers 01/25/11 Seattle
How ZymoGenetics Coulda Been a Contender: The Big Break That Came Too Late 01/25/11 Seattle
Dendreon’s European Plan, Williams Heads East, Allozyne Passes Clinical Trial, & More Seattle-Area Life Sciences News 01/13/11 Seattle
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News 01/07/11 Boston
Biogen Idec’s New R&D Boss, Doug Williams, Spurns Corner Office for a Return to Big Science 01/06/11 Boston
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team 01/05/11 Boston
Editor’s Picks: The Best of 2010 From Xconomy Seattle 12/23/10 Seattle
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News 11/11/10 Seattle
Q&A With Doug Williams: Reflecting on ZymoGenetics, Looking Ahead at Seattle Biotech 11/09/10 Seattle
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster 10/26/10 Seattle
Page 1 of 6 next page »